04/17/2024
4:14 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:32 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
5:07 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:59 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:01 PM | Denali Therapeutics (Filer)
| Form S-3ASR | |
03/01/2024
3:51 PM | Denali Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/27/2024
7:03 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/27/2024
7:07 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
4:38 PM | Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:38 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:02 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
8:14 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
8:14 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
8:15 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
8:16 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:43 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:22 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:17 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:18 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:19 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
6:07 PM | BIOGEN INC. (Filed by)
Denali Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
5:59 AM | BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
5:40 AM | Denali Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
| Form SC 13G/A | |
01/18/2024
5:26 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:23 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
7:18 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:28 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:09 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
6:34 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:35 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:33 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:34 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:20 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:06 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
7:25 PM | Denali Therapeutics (Subject)
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:27 PM | Denali Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:27 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:21 PM | Denali Therapeutics (Subject)
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:23 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
4:57 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:57 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
01/05/2024
4:56 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
6:30 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:14 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:44 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
3:16 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2023
4:06 PM | Cole Douglas G. (Reporting)
Denali Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/05/2023
3:31 PM | Cole Douglas G. (Reporting)
Denali Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
3:45 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
4:26 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023
4:30 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
4:36 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:31 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:32 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:33 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:34 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
1:41 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
1:43 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
1:45 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
1:47 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
5:42 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
5:19 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
5:20 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
3:34 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
4:11 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:12 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:13 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
1:44 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
1:45 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023
4:09 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
4:10 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:12 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
3:40 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
4:21 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
4:14 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
6:03 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:37 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
4:59 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:01 PM | Cole Douglas G. (Reporting)
Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:02 PM | Denali Therapeutics (Issuer)
Harris Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:03 PM | Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:04 PM | Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:04 PM | Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:05 PM | Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:06 PM | Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:07 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
5:08 PM | Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
7:12 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
1:53 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
